Introduction: Leishmaniasis broadly manifests as visceral leishmaniasis (VL), cutaneous
leishmaniasis (CL) and mucocutaneous leishmaniasis. The treatment of leishmaniasis is …

Introduction: Leishmaniasis is a vector-borne neglected tropical disease which manifests as
visceral leishmaniasis (VL), cutaneous leishmaniasis (CL), and mucocutaneous …

Leishmania infections span a range of clinical syndromes and impact humans from many
geographic foci, but primarily the world's poorest regions. Transmitted by the bite of a female …

Leishmaniases are worldwide zoonotic infectious diseases caused by different types of
intracellular protozoan species of the genus Leishmania. Leishmaniasis as an important …

The application of 1 H NMR spectroscopy and chemometrics for the analysis of extracts of
Lantana camara is described. This approach allowed to predict the leishmanicidal activity of …

Abstract Herein, a 28-year-old man with hoarseness, skin and oral lesions is presented. At
the time of admission, the patient had an erythematous plaque on his chin near his lower lip …

This report describes a case of mucosal leishmaniasis caused by Leishmania major with
destructive perforation of the nasal septum illustrating the diagnostic challenges of a rare …

Abstract The World Health Organization's (WHO) recommendation is 28-day course of
meglumine antimoniate (Glucantime®, Sanofi Aventis, France) for the treatment of visceral …

Although leishmaniasis is an endemic disease in Iran the mucosal involvement is rare.
Mucocutaneous leishmaniasis (MCL) mainly caused by Leishmanial braziliensis infection …

: Background: Statin treatment can cause elevation of the liver aminotransferase levels in 1-
3% of the patients with hypercholesterolemia. Previous studies indicate that vitamin E plays …